PerkinElmer is hoping that a variety of life science research instruments it launched in 2005 will drive revenue in 2006 and help the firm meet its forecast of 5-percent to 7-percent organic growth this year.

Company officials said during a conference call last week that they expect the shift in the firm's product mix in 2005 to match the market's "migration of applications." Specifically, they believe PerkinElmer's growing focus on cell analysis and protein biomarkers should fuel revenue growth.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.